HIGHFDA DRUG

Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
May 28, 2026
Status
ACTIVE

Quick Facts at a Glance

Recall Date
May 28, 2026
Hazard Level
HIGH
Brands
FENOFIBRATE, Ajanta Pharma USA Inc.
Geographic Scope
1 states

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
FENOFIBRATE, Ajanta Pharma USA Inc.
Model numbers
Lot # PA02216, Exp. 12/2029
UPC codes
27241-118, 27241-119, 27241-120, 27241-118-04, 27241-118-05, 27241-119-04, 27241-119-05, 27241-120-04 +1 more
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    May 28, 2026

  2. Reported by FDA DRUG

    July 1, 2026

  3. RecallRadar source check

    July 7, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Ajanta Pharma USA Inc or your healthcare provider for guidance. Notification method: N/A

Get instant alerts for FENOFIBRATE recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.. Generic: FENOFIBRATE; Brand: FENOFIBRATE. Reason: CGMP Deviations. Classification: Class II. Quantity: 3648 bottles. Distribution: U.S. Nationwide

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot # PA02216
Exp. 12/2029
UPC Codes
27241-118
27241-119
27241-120
+6 more
Affected States
ALL
Report Date
July 1, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls